Stamatios Makrigiannis CARDIOLOGIST CLINICAL Interventional Cardiologist, 1st Cardiology Department

“Prognostic value of C-reactive protein in patients submitted to reperfusion due to myocardial in-farction”. National and Kapodistrian University of Athens, Medical School, 2013

• Fellow of the European Society of Cardiology (ESC)
• Member of the Hellenic Cardiological Society (HCS)
• Member of the European Association of Percutaneous Cardiovascular Interventions
• Member of the Acute Cardiovascular Care Association
• Member of the Hellenic Medical Society for the Study of Risk Factors in Cardiovascular Disease
• Member of the Working group of Haemodynamic and Interventional Cardiology of the HSC
• Member of the Working group of Prevention and Rehabilitation of the HSC

AD-HOC REVIEWER for peer-reviewed international journals

• American Journal of Cardiology
• Journal of Critical Care

• 1st Cardiology Department, HYGEIA Hospital (since 2013)
• Intensive Care Unit, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2011-2013)
• Cardiology Department, “ΤΖΑΝΕΙΟ” General Hospital of Piraeus (2006 – 2010) 
• 1st Department of Internal Medicine, “ΜΕΤΑXΑ” Hospital of Piraeus (2002-2004)

Clinical Interest

• Invasive treatment of coronary artery disease, especially using radial approach 
• Acute and intensive cardiac care
• Heart Failure 
• Antithrombotic treatment in atrial fibrillation and acute coronary syndromes

Research Interest

• Pathophysiologic mechanisms in coronary artery disease
• Optimization of transradial techniques in percutaneous interventions
• Biomarkers in acute coronary syndromes
• Antithrombotic treatment in atrial fibrillation

• Fellow of the European Society of Cardiology (FESC)
• Educational grant from the Hellenic Cardiological Society (Interventional Cardiology training) , 2013
• Hellenic Cardiological Society research awards and protocol funding for the years 2012 to 2015

• “Non ST-segment elevation Acute Coronary Syndromes”. Book Chapter in “Καρδιολογικά Προβλήματα στην Κλινική Πράξη” [Challenges in Clinical Practice -in Greek] G.B Parisianos Medical Publications 2010. ISBN 978-960-99126-6-2
• “Atheromatous plaque – Diagnostic approach of the vulnerable plaque”. Book Chapter in “Καρδιομεταβολικός Κίνδυνος” [Cardiometabolic risk -in Greek] G.B Parisianos Medical Publications 2007. ISBN 978-960-89486-2-4
• “Introduction to the Cardiological Electronic Patient Record” In.Ι.Ε.S.Α.P Scientific Publications 2006. ISBN 960-89043-0-7

• New-onset atrial fibrillation and clinical outcome in non-cardiac intensive care unit patients. Aust Crit Care 2017;S1036-7314:30007-3.
• Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures. J Thromb Thrombolysis 2017;44:9-13.
• A perilous journey through the heart: Ventricular tachycardia caused by a foreign body. Hellenic J Cardiol 2016;S1109-9666:30194-4.
• Gastrointestinal bleeding in patients receiving antiplatelet and anticoagulant therapy: practical guidance for restarting therapy and avoiding recurrences. Hellenic J Cardiol 2014;55:499-509. 
• Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients. J Crit Care 2014;29:697.e1-5.
• Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction. Am J Cardiol 2013;111: 26-30.
• Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart 2012;98:860-4.
• Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2010;141:284-90.
• The impact of right ventricular involvement on the postdischarge long-term mortality in patients with acute inferior ST-segment elevation myocardial infarction. Angiology 2010;61:179-83.
• The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes. Clin Cardiol 2009;32:142-7.